<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02351479</url>
  </required_header>
  <id_info>
    <org_study_id>Bantum-2013-2</org_study_id>
    <nct_id>NCT02351479</nct_id>
  </id_info>
  <brief_title>Hula, a Physical Activity Intervention for Female-Cancer Survivors</brief_title>
  <official_title>Hula, a Physical Activity Intervention for Female-Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Hawaii</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Hawaii</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A six-month interventional program to determine the biological and psychosocial effects of
      hula as a form of physical activity for female breast, cervical, endometrial or ovarian
      cancer survivors living on Oahu.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hula Program Feasibility (Compliance as measured by the proportion of total sessions attended and a questionnaire regarding satisfaction with the program at the end of the intervention)</measure>
    <time_frame>6 months after the start of the intervention program</time_frame>
    <description>Compliance as measured by the proportion of total sessions attended and a questionnaire regarding satisfaction with the program at the end of the intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biomarkers - Sex Hormones (Circulating levels of sex hormones measured in serum samples)</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
    <description>Circulating levels of sex hormones measured in serum samples.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers - Cytokines (Circulating levels of cytokines measured in serum samples.)</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
    <description>Circulating levels of cytokines measured in serum samples.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers - Inflammatory Markers (Circulating levels of leptin, CRP, IGF-1, and IGFBP3 measured in serum samples collectively.)</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
    <description>Circulating levels of leptin, CRP, IGF-1, and IGFBP3 measured in serum samples collectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DNA Methylation Patterns (DNA methylation patterns as detected with the Illumina Assay containing methylation sites in RefSeq genes and CpG islands collectively.)</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
    <description>DNA methylation patterns as detected with the Illumina Assay containing methylation sites in RefSeq genes and CpG islands collectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Report Outcomes - Demographics (Collectively looking at demographic items as measured on the baseline questionnaire, including ethnicity, education, family, history of cancer, stage of cancer, treatment type, and comorbidities.)</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
    <description>Collectively looking at demographic items as measured on the baseline questionnaire, including ethnicity, education, family, history of cancer, stage of cancer, treatment type, and comorbidities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Report Outcomes - Physical Activity (Minutes per week of exercise assessed using The Women's Health Initiative Physical Activity Questionnaire)</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
    <description>Minutes per week of exercise assessed using The Women's Health Initiative Physical Activity Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Report Outcomes - Health-Related Quality of Life (Quality of life of participants assessed using The European Organization for Research and Treatment of Cancer QLQ-C30.)</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Report Outcomes - Fatigue (assessed using The Brief Fatigue Inventory (BFI)</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
    <description>The severity and impact of fatigue on daily functioning assessed using The Brief Fatigue Inventory (BFI).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Report Outcomes - Depression (indicated using The Centers for Epidemiological Studies Depression Scale (CES-ED)</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
    <description>The presence of depression as indicated using The Centers for Epidemiological Studies Depression Scale (CES-ED).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Report Outcomes - Affective States (assessed using The Profile of Mood States short form (POMS-SF) questionnaire.)</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
    <description>Affect of participants assessed using The Profile of Mood States short form (POMS-SF) questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Report Outcomes - Social Constraints (assessed using The 10-item Social Constraints Scale.)</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
    <description>How people adjust and cope with a cancer diagnosis assessed using The 10-item Social Constraints Scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Report Outcomes - Cognitive Functioning (assessed using the 42-item FACTcog</measure>
    <time_frame>Baseline, 6 months and 12 months after the start of the intervention program</time_frame>
    <description>2 subscales assess cognitive deficiency and cognitive capability</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Physical Activity</condition>
  <condition>Breast Cancer</condition>
  <condition>Cervical Cancer</condition>
  <condition>Ovarian Cancer</condition>
  <condition>Endometrial Cancer</condition>
  <arm_group>
    <arm_group_label>Hula</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hula is an ancient, Native Hawaiian dance form of cultural expression and physical activity. Participants will attend one-hour hula classes twice a week for six months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Hula</intervention_name>
    <arm_group_label>Hula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lives on Oahu

          -  Diagnosed with primary breast,cervical, endometrial or ovarian cancer (stage I-III)

          -  Completed initial regional and systemic treatment for breast cancer 2 months ago

          -  Physically capable of doing the hula-based physical activity

          -  Receives approval by attending physician to participate in trial

        Exclusion Criteria:

          -  Currently undergoing chemotherapy or radiation therapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erin Bantum, MA, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Hawaii Cancer Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Hawaii Cancer Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2015</study_first_submitted>
  <study_first_submitted_qc>January 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2015</study_first_posted>
  <last_update_submitted>November 7, 2016</last_update_submitted>
  <last_update_submitted_qc>November 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hula</keyword>
  <keyword>breast cancer</keyword>
  <keyword>female</keyword>
  <keyword>hawaii</keyword>
  <keyword>physical activity</keyword>
  <keyword>cervical cancer</keyword>
  <keyword>ovarian cancer</keyword>
  <keyword>endometrial cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

